ArticleClinical kidney journal2022

Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant.

Karyne Pelletier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.